Strides Pharma reports Q1FY27 revenue of ₹12,654m, up 13% YoY

Strides Pharma reports Q1FY27 revenue of ₹12,654m, up 13% YoY. Revenue reached ₹12,654 million, growing 13% YoY, driven by strong performance in international markets. Ex-US markets surged 17% YoY, indicating robust global demand. The company delivered a steady operational performance despite ongoing regulatory challenges in key geographies.

📊 STOCKS: $STRAIPPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Earnings